email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2596 - 2610
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Zai Lab Launches Electric Field Treatment for GBM in Hong Kong
$5.00
Available
Shanghai Industrial Investment to Launch $7.3 Billion Biomedical Fund Next Year
$5.00
Available
Bio-Thera Files to Start China Trials of Cancer Antibody Drug Conjugate
$5.00
Available
FibroGen/AstraZeneca Novel Anemia Drug Approved in China -- Before US/EU Approvals
$5.00
Available
Innovent/Lilly PD-1 Approved in China for Hodgkin's Lymphoma
$5.00
Available
Xynomic Files Three China INDs for Lead Oncology Candidate
$5.00
Available
Venus Medtech Merges with Keystone in China-Israel Medical Device Tie-up
$5.00
Available
Crystal Pharmatech, a China-US Drug Manufacturing Process CRO, Raises $14.5 Million
$5.00
Available
Junshi Biosciences Rises 22% Following $394 Million Hong Kong IPO
$5.00
Available
Shanghai Cell Therapy Closes $136 Million C Round
$5.00
Available
Xynomic Acquires Boehringer Cancer Candidate in $800 Million Deal
$5.00
Available
Ascentage and Genor to Collaborate on Immunotherapy Combination
$5.00
Available
Gan & Lee Out-Licenses Ex-China Rights for Three Diabetes Biosimilars to Sandoz
$5.00
Available
GenomiCare Completes $30 Million Round for China Precision Medicine
$5.00
Available
Autobio Forms $19 Million China IVD JV with Mobidiag and Invests $11.4 Million in the Company
$5.00
Available